Binding to surface sugars enhances omicron variant's cell attachment, researchers discover
Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...
A hidden strategy: How SARS-CoV-2 uses fibrinogen to evade the immune system
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...
AZoLifeSciences on MSN4d
New AI Model Helps Predict Future Mutations in SARS-CoV-2 Spike Protein
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
AI learns to 'speak' genetic 'dialect' for future SARS-CoV-2 mutation prediction
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
C&EN6d
Antiviral unveiled that goes after multiple coronaviruses
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.